Drug‐induced reduction in estimated glomerular filtration rate in patients with ALK‐positive non‐small cell lung cancer treated with the ALK inhibitor crizotinib

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|120|5|664-674

ISSN: 0008-543x

Source: CANCER, Vol.120, Iss.5, 2014-03, pp. : 664-674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract